GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hwail Pharm Co Ltd (XKRX:061250) » Definitions » Cyclically Adjusted PB Ratio

Hwail Pharm Co (XKRX:061250) Cyclically Adjusted PB Ratio : 0.56 (As of May. 26, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Hwail Pharm Co Cyclically Adjusted PB Ratio?

As of today (2024-05-26), Hwail Pharm Co's current share price is ₩1557.00. Hwail Pharm Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ₩2,795.99. Hwail Pharm Co's Cyclically Adjusted PB Ratio for today is 0.56.

The historical rank and industry rank for Hwail Pharm Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

XKRX:061250' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.56   Med: 1.01   Max: 2.19
Current: 0.56

During the past years, Hwail Pharm Co's highest Cyclically Adjusted PB Ratio was 2.19. The lowest was 0.56. And the median was 1.01.

XKRX:061250's Cyclically Adjusted PB Ratio is ranked better than
84.83% of 692 companies
in the Drug Manufacturers industry
Industry Median: 1.89 vs XKRX:061250: 0.56

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Hwail Pharm Co's adjusted book value per share data for the three months ended in Mar. 2024 was ₩2,355.979. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩2,795.99 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Hwail Pharm Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Hwail Pharm Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hwail Pharm Co Cyclically Adjusted PB Ratio Chart

Hwail Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.91 1.72 1.03 1.03 0.79

Hwail Pharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.74 0.75 0.75 0.79 0.59

Competitive Comparison of Hwail Pharm Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Hwail Pharm Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hwail Pharm Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hwail Pharm Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Hwail Pharm Co's Cyclically Adjusted PB Ratio falls into.



Hwail Pharm Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Hwail Pharm Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1557.00/2795.99
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hwail Pharm Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Hwail Pharm Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2355.979/118.8477*118.8477
=2,355.979

Current CPI (Mar. 2024) = 118.8477.

Hwail Pharm Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 2,153.045 99.353 2,575.508
201409 2,169.756 99.608 2,588.853
201412 2,195.538 99.098 2,633.097
201503 2,180.975 99.720 2,599.317
201506 2,212.646 100.050 2,628.365
201509 2,220.537 100.110 2,636.157
201512 2,438.923 100.220 2,892.241
201603 2,485.426 100.560 2,937.422
201606 2,509.049 100.790 2,958.574
201609 2,517.509 101.460 2,948.947
201612 2,461.517 101.560 2,880.520
201703 2,416.390 102.850 2,792.245
201706 2,415.216 102.610 2,797.416
201709 2,444.205 103.490 2,806.920
201712 2,420.060 102.990 2,792.684
201803 2,407.537 104.100 2,748.609
201806 2,447.652 104.130 2,793.602
201809 2,473.636 105.650 2,782.640
201812 2,495.649 104.350 2,842.378
201903 2,479.814 104.490 2,820.559
201906 2,500.268 104.880 2,833.248
201909 2,510.112 105.200 2,835.751
201912 2,426.697 105.120 2,743.601
202003 2,422.422 105.540 2,727.869
202006 2,439.074 104.870 2,764.168
202009 2,544.395 106.200 2,847.415
202012 2,616.876 105.765 2,940.562
202103 2,720.054 107.357 3,011.183
202106 2,741.963 107.579 3,029.190
202109 2,758.262 108.759 3,014.118
202112 2,767.755 109.676 2,999.199
202203 2,781.050 111.806 2,956.210
202206 2,798.374 114.083 2,915.254
202209 2,716.598 114.831 2,811.615
202212 2,638.899 115.200 2,722.453
202303 2,657.985 116.550 2,710.395
202306 2,669.605 117.140 2,708.526
202309 2,745.194 119.111 2,739.121
202312 2,717.651 118.848 2,717.651
202403 2,355.979 118.848 2,355.979

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hwail Pharm Co  (XKRX:061250) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Hwail Pharm Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Hwail Pharm Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hwail Pharm Co (XKRX:061250) Business Description

Traded in Other Exchanges
N/A
Address
904-7, Sangsin-Ri, Hyangnam-Eup, Hwaseong, Gyeonggi, KOR, 445-746
Hwail Pharm Co Ltd is engaged in manufacturing and distribution of raw materials used in pharmaceutical production. Its products include antitussive expectorants, spasmolytic, stomach function modifier, anti-inflammatory, and others.

Hwail Pharm Co (XKRX:061250) Headlines

No Headlines